Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
Australian School of Petroleum
Business School
Elder Conservatorium of Music
Law School
School of Agriculture, Food and Wine
School of Animal and Veterinary Sciences
School of Architecture and Built Environment
School of Chemical Engineering
School of Chemistry and Physics
School of Civil, Environmental and Mining Engineering
School of Computer Science
School of Dentistry
School of Earth and Environmental Sciences
School of Economics
School of Education
School of Electrical and Electronic Engineering
School of History and Politics
School of Humanities
School of Mathematical Sciences
School of Mechanical Engineering
School of Medical Sciences
School of Medicine
School of Molecular and Biomedical Science
School of Nursing
School of Paediatrics & Reproductive Health
School of Population Health & Clinical Practice
School of Psychology
School of Social Sciences
School of Translational Health Science
Research Outputs
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 91-100 of 127 (Search time: 0.004 seconds).
previous
1
...
7
8
9
10
11
12
13
next
Item hits:
Preview
Issue Date
Title
Author(s)
2009
Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
Apperley, J.
;
Cortes, J.
;
Kim, D.
;
Roy, L.
;
Roboz, G.
;
Rosti, G.
;
Bullorsky, E.
;
Abruzzese, E.
;
Hochhaus, A.
;
Heim, D.
;
De Souza, C.
;
Larson, R.
;
Lipton, J.
;
Khoury, J.
;
Kim, H.
;
Sillaber, C.
;
Hughes, T.
;
Erben, P.
;
Tornout, J.
;
Stone, R.
2010
Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in Type 2 diabetic CML patients?
Fitter, S.
;
Vandyke, K.
;
Schultz, C.
;
White, D.
;
Hughes, T.
;
Zannettino, A.
2011
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results
Kantarjian, H.
;
Giles, F.
;
Bhalla, K.
;
Pinilla-Ibarz, J.
;
Larson, R.
;
Gattermann, N.
;
Ottmann, O.
;
Hochhaus, A.
;
Radich, J.
;
Saglio, G.
;
Hughes, T.
;
Martinelli, G.
;
Kim, D.
;
Shou, Y.
;
Gallagher, N.
;
Blakesley, R.
;
Baccarani, M.
;
Cortes, J.
;
le Coutre, P.
2011
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after Imatinib resistance is predictive of outcome during subsequent therapy
Parker, W.
;
Lawrence, R.
;
Ho, M.
;
Irwin, D.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2012
Classification of patients with chronic myeloid leukemia on basis of BCR-ABL transcript level at 3 months fails to identify patients with low organic cation transporter-1 activity destined to have poor imatinib response
White, D.
;
Hughes, T.
2004
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
Branford, S.
;
Rudzki, Z.
;
Parkinson, I.
;
Grigg, A.
;
Taylor, K.
;
Seymour, J.
;
Durrant, S.
;
Browett, P.
;
Schwarer, A.
;
Arthur, C.
;
Catalano, J.
;
Leahy, M.
;
Filshie, R.
;
Bradstock, K.
;
Herrmann, R.
;
Joske, D.
;
Lynch, K.
;
Hughes, T.
2011
Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells
Tang, M.
;
Gonen, M.
;
Quintas-Cardama, A.
;
Cortes, J.
;
Kantarjian, H.
;
Field, C.
;
Hughes, T.
;
Branford, S.
;
Michor, F.
2012
Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile
Parker, W.
;
Ho, M.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2012
Initial molecular response at 3 months may predict both response and event-free survival at 24 months in Imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with Nilotinib
Branford, S.
;
Kim, D.
;
Soverini, S.
;
Haque, A.
;
Shou, Y.
;
Woodman, R.
;
Kantarjian, H.
;
Martinelli, G.
;
Radich, J.
;
Saglio, G.
;
Hochhaus, A.
;
Hughes, T.
;
Muller, M.
2007
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
White, D.
;
Saunders, V.
;
Dang, P.
;
Engler, J.
;
Venables, A.
;
Zrim, S.
;
Zannettino, A.
;
Lynch, K.
;
Manley, P.
;
Hughes, T.
Discover
Author
37
White, D.
30
Branford, S.
24
Hochhaus, A.
14
Radich, J.
14
To, L.
13
Kantarjian, H.
13
Saglio, G.
13
Saunders, V.
13
Townsend, G.
13
Zannettino, A.
.
next >
Subject
74
Leukemia, Myelogenous, Chronic, B...
73
Pyrimidines
63
Imatinib Mesylate
61
Piperazines
60
Benzamides
46
Antineoplastic Agents
45
Female
44
Male
43
Fusion Proteins, bcr-abl
41
Protein Kinase Inhibitors
.
next >
Date issued
6
2020 - 2022
52
2010 - 2019
65
2000 - 2009
4
1995 - 1999